VYVGART
Google image searchProduct monograph
Active ingredient
efgartigimod alfa, 20 MG/ML
DIN: 02541599
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: ARGENX BV
Date: 06-NOV-2023
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AL — Neonatal fragment crystallizable receptor (FcRn) inhibitors (ATC, ATC/DDD)
- L04AL01 — EFGARTIGIMOD ALFA (ATC/DDD)
Reference brand drug: Vyvgart
